Milan: gains for Pharmanutra
(Teleborsa) - The Pharmaceutical company specialized in the development of nutraceutical supplements and medical devices increases its performance, climbing +2.51%.On a weekly basis, the stock is trending higher than the FTSE Italia Mid Cap. The performance of Pharmanutra, in fact, has been higher than the related benchmark index.
Short-term analysis of Pharmanutra confirms that the security's bullish phase is to continue, with immediate resistance seen at 53.33 Euros and the first support identified at 52.33. Technically, we can expect further upward movement towards new highs in the 54.33 region.
These analyses are to be considered solely for information purposes and are not in any way intended to constitute financial advice, a solicitation of funds from the public or the promotion of any form of investment.
(Teleborsa Research Department)
(Teleborsa) 30-08-2024 12:30